Ik-Hwan Han

Research professor

Kyungpook National University

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ik-Hwan Han is a Research Professor at Kyung Hee University in South Korea. His research areas include tumor immunology, specifically focusing on M2-like tumor-associated macrophages and their role in cancer progression. Recent articles authored by him explore innovative therapeutic strategies targeting these macrophages to combat various cancers and related diseases.

Articles (16)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Seung-Hyeok Park

Clinical assistant professor

Kyung Hee University Hospital at Gangdong

SOUTH KOREA

View details

Hyunsu Bae

Professor

Kyungpook National University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ik-Hwan Han

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

The Combination of CD300c Antibody with PD-1 Blockade Suppresses Tumor Growth and Metastasis by Remodeling the Tumor Microenvironment in Triple-Negative Breast Cancer

Conformation-sensitive targeting of CD18 depletes M2-like tumor-associated macrophages resulting in inhibition of solid tumor progression

Therapeutic effects of MEL-dKLA by targeting M2 macrophages in pulmonary fibrosis

Inflammatory response to Trichomonas vaginalis in the pathogenesis of prostatitis and benign prostatic hyperplasia

The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain

The involvement of the noradrenergic system in the antinociceptive effect of cucurbitacin D on mice with paclitaxel-induced neuropathic pain

Melittin derived peptide-drug conjugate, M-DM1, inhibits tumor progression and induces effector cell infiltration in melanoma by targeting M2 tumor-associated macrophages

Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer

Bee venom phospholipase A2 ameliorates amyotrophic lateral sclerosis by increasing regulatory T cell population

Therapeutic Effect of Melittin–dKLA Targeting Tumor-Associated Macrophages in Melanoma

Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer

Therapeutic Effect of Melittin-dKLA Targeting Tumor-Associated Macrophages in Melanoma

TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer

TAMpepK Suppresses Metastasis through the Elimination of M2-Like Tumor-Associated Macrophages in Triple-Negative Breast Cancer

Screening of phytochemicals effective on relieving cancer cachexia in cisplatin-induced in vitro sarcopenia model

Combination of anti-PD-L1 antibody with peptide MEL-dKLA targeting M2 tumor-associated macrophages suppresses breast cancer metastasis

Collaborators (2)

Seung-Hyeok Park

Hyunsu Bae

Make your next move.